These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4997865)

  • 1. Serological specificity of type E botulinal toxin.
    Johnson HM; Smith BG; Lewis KH
    Proc Soc Exp Biol Med; 1971 Jul; 137(3):973-6. PubMed ID: 4997865
    [No Abstract]   [Full Text] [Related]  

  • 2. Serological studies of types A, B, and E botulinal toxins by passive hemagglutination and bentonite flocculation.
    Johnson HM; Brenner K; Angelotti R; Hall HE
    J Bacteriol; 1966 Mar; 91(3):967-74. PubMed ID: 5326104
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of antibody to each component of Clostridium botulinum type E progenitor toxin.
    Sakaguchi G; Sakaguchi S
    Jpn J Med Sci Biol; 1973 Dec; 26(5):187-95. PubMed ID: 4601357
    [No Abstract]   [Full Text] [Related]  

  • 4. Experimental studies on the serum therapy of type E botulism: the relationship between the amount of toxin in the blood and the effect of antitoxic serum.
    Iida H; Ono T; Karashimada T
    Jpn J Med Sci Biol; 1970 Oct; 23(5):344-7. PubMed ID: 4993667
    [No Abstract]   [Full Text] [Related]  

  • 5. The partial reactivation of formalin-inactivated Clostridium botulinum type C toxin.
    MARTY EW
    Am J Vet Res; 1961 Jul; 22():770-4. PubMed ID: 13767602
    [No Abstract]   [Full Text] [Related]  

  • 6. Determination of botulinum toxin type by the reaction of indirect hemagglutination inhibition.
    Reiss J; Wojtyła B
    Arch Immunol Ther Exp (Warsz); 1981; 29(1):97-108. PubMed ID: 7025794
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A simple method for purification of type E botulinal toxin from the precursor extract of the bacterial cells.
    SAKAGUCHI G; SAKAGUCHI S
    Jpn J Med Sci Biol; 1961 Dec; 14():243. PubMed ID: 14496146
    [No Abstract]   [Full Text] [Related]  

  • 8. Botulinal toxin and toxoid as antigens.
    Heimach RC; Champion LA; Sugiyama H
    Proc Soc Exp Biol Med; 1970 Oct; 135(1):151-4. PubMed ID: 4920940
    [No Abstract]   [Full Text] [Related]  

  • 9. Phagocytosis of staphylococci by mouse leukocytes in the presence of botulinum toxin.
    FREEMAN NL
    J Bacteriol; 1961 Jan; 81(1):156-7. PubMed ID: 13701643
    [No Abstract]   [Full Text] [Related]  

  • 10. Clostridium botulinum subtype Ba.
    Giménez DF
    Zentralbl Bakteriol Mikrobiol Hyg A; 1984 May; 257(1):68-72. PubMed ID: 6380157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antigenic variations in F type botulinum toxins. Attempted definitions by serological typing and classification of Clostridium botulinum].
    Gimenez DF; Ciccarelli AS
    Medicina (B Aires); 1972; 32(6):596-606. PubMed ID: 4576316
    [No Abstract]   [Full Text] [Related]  

  • 12. The lack of identity between hemagglutinin and the toxin of type A botulinal organism.
    LAMANNA C; LOWENTHAL JP
    J Bacteriol; 1951 Jun; 61(6):751-2. PubMed ID: 14850434
    [No Abstract]   [Full Text] [Related]  

  • 13. Cross reaction in reversed passive hemagglutination between Clostridium botulinum type A and B toxins and its avoidance by the sue of anti-toxic component immunoglobulin isolated by affinity chromatography.
    Sakaguchi G; Sakaguchi S; Kozaki S; Sugii S; Oishi I
    Jpn J Med Sci Biol; 1974 Jun; 27(3):161-72. PubMed ID: 4604281
    [No Abstract]   [Full Text] [Related]  

  • 14. Hemagglutination by botulinal toxin.
    LAMANNA C
    Proc Soc Exp Biol Med; 1948 Nov; 69(2):332-6. PubMed ID: 18102220
    [No Abstract]   [Full Text] [Related]  

  • 15. Studies on immunity to toxins of Clostridium botulinum. VII. Purification and detoxification of trypsin-activated type E toxin.
    FIOCK MA; YARINSKY A; DUFF JT
    J Bacteriol; 1961 Jul; 82(1):66-71. PubMed ID: 13699727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Research in vitro on toxigenesis of Cl. tetani and Cl. botulinum].
    D'ARCA SIMONETTI A
    Nuovi Ann Ig Microbiol; 1959; 10():342-58. PubMed ID: 13813594
    [No Abstract]   [Full Text] [Related]  

  • 17. Antigenic and chromatographic identity of two apparently distinct toxins of Clostridium botulinum type A.
    Hauschild AH; Hilsheimer R
    Can J Microbiol; 1969 Oct; 15(10):1129-32. PubMed ID: 4905857
    [No Abstract]   [Full Text] [Related]  

  • 18. Antigenicites of fragments of Clostridium botulinum type B derivative toxin.
    Kozaki S; Sakaguchi G
    Infect Immun; 1975 May; 11(5):932-6. PubMed ID: 804447
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Studies on immunity to toxins of Clostridium botulinum. VI. Purification and detoxification of type D toxin and the immunological response to toxoid.
    CARDELLA MA; DUFF JT; WINGFIELD BH; GOTTFRIED C
    J Bacteriol; 1960 Mar; 79(3):372-8. PubMed ID: 13807649
    [No Abstract]   [Full Text] [Related]  

  • 20. Significance of 12S toxin of Clostridium botulinum type E.
    Kitamura M; Sakaguchi S; Sakaguchi G
    J Bacteriol; 1969 Jun; 98(3):1173-8. PubMed ID: 4977983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.